Back to Search
Start Over
Emerging drugs for the treatment of adrenocortical carcinoma
- Source :
- Expert Opinion on Emerging Drugs. 26:165-178
- Publication Year :
- 2021
- Publisher :
- Informa UK Limited, 2021.
-
Abstract
- Introduction: Adrenocortical cancer (ACC) is a rare and aggressive disease with a median survival of 14–17 months and 5-year survival of around 20% for advanced disease. Emerging evidence of sub-gr...
- Subjects :
- Oncology
medicine.medical_specialty
Immune checkpoint inhibitors
medicine.medical_treatment
Aggressive disease
030226 pharmacology & pharmacy
Targeted therapy
03 medical and health sciences
Antineoplastic Agents, Immunological
0302 clinical medicine
Internal medicine
Adrenocortical Carcinoma
Advanced disease
medicine
Animals
Humans
Adrenocortical carcinoma
Pharmacology (medical)
Immune Checkpoint Inhibitors
Pharmacology
business.industry
Wnt signaling pathway
medicine.disease
Adrenal Cortex Neoplasms
Survival Rate
Drug Design
030220 oncology & carcinogenesis
business
Adrenocortical cancer
Median survival
Subjects
Details
- ISSN :
- 17447623 and 14728214
- Volume :
- 26
- Database :
- OpenAIRE
- Journal :
- Expert Opinion on Emerging Drugs
- Accession number :
- edsair.doi.dedup.....6495dc266af2dc5013365815224d3f1c
- Full Text :
- https://doi.org/10.1080/14728214.2021.1920922